Add a Comment
Save my information
One statement runs counter to a point that I thought a speaker made at the NASW-Lisner session on stem-cell therapies. If I understood him correctly, besides testing a drug on bacteria and animals, drug companies look for toxicity to human cell lines well before proceeding to clinical trials.
A different, small matter: there are a number of typos in the article that i suspect a human proofreader would have caught.